Stock DNA
Specialty Chemicals
INR 1,899 Cr (Small Cap)
42.00
42
1.46%
0.60
7.03%
1.40
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Feb-13-2026
Risk Adjusted Returns v/s 
Returns Beta
News

S H Kelkar & Company Ltd Valuation Shifts to Very Attractive Amid Market Downturn
S H Kelkar & Company Ltd, a small-cap player in the Specialty Chemicals sector, has seen a significant shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite a sharp decline in its share price over recent months, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for value investors, especially when compared to its peers and historical benchmarks.
Read More
S H Kelkar & Company Ltd Downgraded to Below Average Quality Amid Deteriorating Fundamentals
S H Kelkar & Company Ltd, a specialty chemicals small-cap, has seen its quality grade downgraded from average to below average, reflecting deteriorating business fundamentals amid a challenging market environment. Key financial metrics such as return on equity (ROE), return on capital employed (ROCE), and earnings growth have weakened, while debt levels remain a concern. This downgrade accompanies a sharp share price decline of 9.7% on 19 May 2026, underscoring investor apprehension.
Read More
S H Kelkar & Company Ltd is Rated Sell by MarketsMOJO
S H Kelkar & Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 Apr 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
21-May-2026 | Source : BSEWe are enclosing herewith the transcript of the Conference Call for Investors and Analysts for Q4 FY26 results
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
18-May-2026 | Source : BSEAudio Recording of Conference Call for Investor and Analysts for Q4 FY 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
16-May-2026 | Source : BSESubmission of Annual Secretarial Compliance Report for the financial year ended March 31 2026
Corporate Actions 
No Upcoming Board Meetings
S H Kelkar & Company Ltd has declared 10% dividend, ex-date: 13 Feb 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
8.2954
Held by 5 Schemes (4.75%)
Held by 54 FIIs (7.42%)
Ramesh Vinayak Vaze Family Trust (ramesh Vaze, Prabha Vaze & Kedar Vaze-in The Capacity Of Trustee) (19.51%)
Firmenich Aromatics Production (india) Pvt Ltd (9.8%)
18.46%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 5.40% vs -4.61% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 255.77% vs -64.10% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 12.02% vs 12.42% in Sep 2024
Growth in half year ended Sep 2025 is 174.25% vs -182.77% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 10.43% vs 13.36% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 330.23% vs -132.99% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 15.35% vs 9.15% in Mar 2024
YoY Growth in year ended Mar 2025 is -40.17% vs 100.13% in Mar 2024